New York – Published on the prestigious international journal “Oncotarget”, a research conducted by a group of researchers from the Section of “Biology and Genetics” of the Department of Biopathology and Medical Biotechnology (DiBiMed) of Palermo could lead to new therapies against Multiple myeloma, a cancer that produces lesions and bone destruction. The disease affects mainly adults with an average incidence of 8 per 100,000. (9Colonne)
